Delivery Order SPE2DB20D3103-SPE2DB23FM1S1

Award Date 1/17/23
Potential Completion Date 1/18/23
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, valued at $1,484.64, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of Phenylephrine 2.5% eye drops, a medical commodity used to support military healthcare programs. The contract has an ultimate completion date of April 21, 2023 and is structured as a firm fixed-price arrangement. This award is part of a larger...
This federal contract award, with an ID of SPE2DB20D7061|SPE2DB24FSNX6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenylephrine 2.5% eye drops, 15 ml, with a ceiling value of $1,450.24 and a completion date of July 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $2,175.53, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply Phenylephrine 2.5% eye drops (15ml) to the DLA. The contract is a firm-fixed price, with an ultimate completion date of February 18, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp is a Firm Fixed Price Delivery Order for the supply of Phenylephrine 2.5% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 10, 2024. The ceiling value of the contract is $1,582.94. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of Phenylephrine 2.5% eye drops, 15 ml, with a ceiling value of $1,196.07. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,133.88 firm-fixed-price delivery order is for the procurement of PHENYLEPHRINE 2.5% EYE DROP 2ML, a medical commodity used for healthcare purposes. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,446.16 firm fixed-price delivery order contract is for the supply of Phenylephrine 2.5% Eye Drop 15ML, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with the identification number SPE2DB22D2007|SPE2DB24FJ5QK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenylephrine 2.5% eye drops, a critical medical product, with a ceiling value of $4,374.95 and a completion date of September 3, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $1,005.84, is for the delivery of Phenylephrine 2.5% eye drops in 15ml bottles. The award was made as a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. government has awarded a Delivery Order contract (SPE2DX15D1053|SPE2DX25F6LLV) worth $2,350.51 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4567796175 - PHENYLEPHRINE 2.5% EYE DROP 15ML. This contract is placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a period of performance through April 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM1S1
    Delivery Order

This federal contract award, valued at $1,068.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Phenylephrine 2.5% eye drops. The contract, which has an ultimate completion date of January 18, 2023, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was made through full and open competition, with no set-aside designation.

Generated 2/27/25, 11:51 AM